, Tracking Stock Market Picks
Enter Symbol:
Aeterna Zentaris, Inc. (AEZS) [hlAlert]

down 97.42 %

Aeterna Zentaris, Inc. (AEZS) rated Buy with price target $11 by Maxim Group

Posted on: Monday,  Nov 23, 2015  8:25 AM ET by Maxim Group

Maxim Group rated Buy Aeterna Zentaris, Inc. (NASDAQ: AEZS) on 11/23/2015. Previously Maxim Group rated Buy Aeterna Zentaris, Inc. (NASDAQ: AEZS) on
10/09/2012., when the stock price was $3.49. Since then, Aeterna Zentaris, Inc. has lost 97.42% as of 12/02/2015's recent price of $0.09.
If you would have followed the previous Maxim Group's recommendation on AEZS, you would have lost 97.42% of your investment in 1149 days.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology. The product pipeline of the Company encompasses compounds at all stages of development, from drug discovery through marketed products. The Company’s principal product candidates include cetrorelix for benign prostatic hyperplasia (BPH) and AEZS-108 for endometrial and ovarian cancers. In January 2007, the Company completed the spin-off of Atrium Biotechnologies Inc., known as Atrium Innovations (Atrium). On November 30, 2007, the Company completed the sale of its Utah-based subsidiary, Echelon Biosciences Inc. (Echelon), to Frontier Scientific Inc.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/23/2015 8:25 AM Buy
4.65 11.00
as of 8/27/2015
1 Week down  -47.05 %
1 Month down  -67.85 %
3 Months down  -79.54 %
1 YTD down  -93.47 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2012 8:25 AM Buy
3.49 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy